“…However, there have been a few reports of syncope and other systemic events.l 41 ,95] The nature and incidence of adverse events reported in elderly users of intracavernous alprostadil are similar to those found in the general populationJ47, 48] The frequency of adverse events associated with intracavernous alprostadil use is affected by a number of factors, possibly including the pH of the formulation, [33,45,50,67,[96][97][98] the dose, [44,51] the amount of training patients receive [67,99] and the type of injection device. However, there have been a few reports of syncope and other systemic events.l 41 ,95] The nature and incidence of adverse events reported in elderly users of intracavernous alprostadil are similar to those found in the general populationJ47, 48] The frequency of adverse events associated with intracavernous alprostadil use is affected by a number of factors, possibly including the pH of the formulation, [33,45,50,67,[96][97][98] the dose, [44,51] the amount of training patients receive [67,99] and the type of injection device.…”